Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37251410)

  • 1. Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancers.
    Talhouni S; Fadhil W; Mongan NP; Field L; Hunter K; Makhsous S; Maciel-Guerra A; Kaur N; Nestarenkaite A; Laurinavicius A; Willcox BE; Dottorini T; Spendlove I; Jackson AM; Ilyas M; Ramage JM
    Front Immunol; 2023; 14():1057292. PubMed ID: 37251410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer.
    Kitakaze M; Uemura M; Hara T; Chijimatsu R; Motooka D; Hirai T; Konno M; Okuzaki D; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Ofusa K; Mizushima T; Eguchi H; Doki Y; Ishii H
    Br J Cancer; 2023 May; 128(10):1828-1837. PubMed ID: 36869093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD103
    Jin K; Yu Y; Zeng H; Liu Z; You R; Zhang H; Liu C; Su X; Yan S; Chang Y; Xu L; Xu J; Zhu Y; Wang Z
    Br J Cancer; 2022 Jun; 126(11):1581-1588. PubMed ID: 35165401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic CD8+ T cells and tissue resident memory cells in colorectal cancer based on microsatellite instability and BRAF status.
    Toh JWT; Ferguson AL; Spring KJ; Mahajan H; Palendira U
    World J Clin Oncol; 2021 Apr; 12(4):238-248. PubMed ID: 33959477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease.
    von Witzleben A; Ellis M; Thomas GJ; Hoffmann TK; Jackson R; Laban S; Ottensmeier CH
    Clin Cancer Res; 2024 Jan; 30(1):224-234. PubMed ID: 37874322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
    Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy.
    Damei I; Trickovic T; Mami-Chouaib F; Corgnac S
    Front Immunol; 2023; 14():1205984. PubMed ID: 37545498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer.
    Workel HH; van Rooij N; Plat A; Spierings DCJ; Fehrmann RSN; Nijman HW; de Bruyn M
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of CD69
    Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
    Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial features of specific CD103
    Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
    J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD103
    Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
    Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity.
    Chen Y; Yan SM; Pu Z; Feng J; Tan L; Li Y; Hu H; Huang W; Lin Y; Peng Z; He X; Huang F; Zhang H; Zhang Y
    Cancer Res; 2022 Sep; 82(17):3130-3142. PubMed ID: 35802647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers.
    Park HS; Jeon Y; Lee H; Lee H; Kim YA; Park IA; Bang WS; Lee M; Cho YJ; Kim J; Gong G; Lee HJ
    Pathobiology; 2022; 89(2):116-126. PubMed ID: 34592745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy.
    Shen YC; Yeh CP; Jeng YM; Hsu C; Hsu CH; Lin ZZ; Shao YY; Lu LC; Liu TH; Chen CH; Cheng AL
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem-like cells evade CD8
    Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of CD103
    Natsuki S; Tanaka H; Nishiyama M; Deguchi S; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K
    BMC Cancer; 2023 Oct; 23(1):1011. PubMed ID: 37864146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Skin Tissue-Resident Memory T Cells in Human Nonmalignant and Premalignant Melanocytic Skin Lesions and in Melanoma.
    Willemsen M; Tio D; Krebbers G; Kasiem FR; Jaspars EH; Matos TR; Bekkenk MW; Bakker WJ; Luiten RM
    Am J Dermatopathol; 2022 Jun; 44(6):416-423. PubMed ID: 35311751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident memory T cells, critical components in tumor immunology.
    Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E
    J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.